Emma Hajaj

463 total citations
8 papers, 242 citations indexed

About

Emma Hajaj is a scholar working on Immunology, Oncology and Biochemistry. According to data from OpenAlex, Emma Hajaj has authored 8 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 2 papers in Biochemistry. Recurrent topics in Emma Hajaj's work include CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Cell Function and Interaction (3 papers). Emma Hajaj is often cited by papers focused on CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Cell Function and Interaction (3 papers). Emma Hajaj collaborates with scholars based in Israel, United States and Canada. Emma Hajaj's co-authors include Ayelet Erez, Marco Sciacovelli, Christian Frezza, Michal Lotem, Galit Eisenberg, Tamar Peretz, Sharon Merims, Shiri Klein, Ravid Straussman and Ron Rotkopf and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Annals of Oncology.

In The Last Decade

Emma Hajaj

8 papers receiving 241 citations

Peers

Emma Hajaj
Fatima Lima United States
Christine Xiao United States
Maria McSharry United States
Adam B. Sendor United States
Fatima Lima United States
Emma Hajaj
Citations per year, relative to Emma Hajaj Emma Hajaj (= 1×) peers Fatima Lima

Countries citing papers authored by Emma Hajaj

Since Specialization
Citations

This map shows the geographic impact of Emma Hajaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Hajaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Hajaj more than expected).

Fields of papers citing papers by Emma Hajaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Hajaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Hajaj. The network helps show where Emma Hajaj may publish in the future.

Co-authorship network of co-authors of Emma Hajaj

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Hajaj. A scholar is included among the top collaborators of Emma Hajaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Hajaj. Emma Hajaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hajaj, Emma, Sabina Pozzi, & Ayelet Erez. (2023). From the Inside Out: Exposing the Roles of Urea Cycle Enzymes in Tumors and Their Micro and Macro Environments. Cold Spring Harbor Perspectives in Medicine. 14(4). a041538–a041538. 7 indexed citations
2.
Hajaj, Emma, Sharon Merims, Jonathan Cohen, et al.. (2021). Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions. Cancer Immunology Research. 9(6). 637–650. 14 indexed citations
3.
Mallel, Giuseppe, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked, et al.. (2021). TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Proceedings of the National Academy of Sciences. 118(23). 72 indexed citations
4.
Hajaj, Emma, Marco Sciacovelli, Christian Frezza, & Ayelet Erez. (2021). The context-specific roles of urea cycle enzymes in tumorigenesis. Molecular Cell. 81(18). 3749–3759. 64 indexed citations
5.
Galsky, Matt D., Xin‐Yuan Guan, Romain Banchereau, et al.. (2021). 658MO Cisplatin (cis)-related immunomodulation and efficacy with atezolizumab (atezo) + cis- vs carboplatin (carbo)-based chemotherapy (chemo) in metastatic urothelial cancer (mUC). Annals of Oncology. 32. S682–S683. 10 indexed citations
6.
Hajaj, Emma, Shiri Klein, Sharon Merims, et al.. (2020). Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study. Frontiers in Oncology. 10. 70–70. 30 indexed citations
7.
Hajaj, Emma, Galit Eisenberg, Shiri Klein, et al.. (2020). SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. eLife. 9. 26 indexed citations
8.
Eisenberg, Galit, Emma Hajaj, Sharon Merims, et al.. (2018). Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo. Cancer Immunology Research. 6(2). 127–138. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026